| Literature DB >> 34728662 |
Hen-Hong Chang1,2, Su-Yin Chiang3, Pei-Chun Chen4, Chia-Han Tsai5, Rong-Chi Yang6, Chiu-Lin Tsai7, Tsung-Hsiu Wu8, Yow-Wen Hsieh9,10, Yu-Chun Lin11, Yung-Te Kuo12, Kuan-Chung Chen13, Hsueh-Ting Chu14.
Abstract
The Taiwan Adverse Drug Reaction Reporting System for Herbal Medicine (TADRRS-HM) has systematically documented suspected adverse events from adverse drug reaction (ADR) reports from 1998 (prior to its formal establishment in 2001) and evaluates safety profiles of herbal medicines. This article describes findings from 2079 ADR reports filed between 1998 and 2016: 941 reports involved single herbs and 87 involved folk herbals; 842 were generated from clinical trials, while 209 ADR reports involving foods, health foods, dietary supplement foods and herbal cuisine were grouped as Other. Severity assessments using the Modified Hartwig and Siegel scale classified 72.4% of ADRs as mild, 17.4% as moderate and 6.5% as severe. System Organ Class classification of the ADRs identified gastrointestinal system disorders as the most common (33.4%), followed by skin and subcutaneous tissue disorders (21.2%). The TADRRS-HM records indicate that herbal medicines may cause a wide range of ADRs. Aconiti Radix, Xiao-Qing-Long-Tang, and Datura suaveolens were the most commonly reported single herb, herbal formula, and folk herbal, respectively. The data indicate that herbal medicines may cause a wide range of ADRs. This system will confer long-term benefits for the development of Taiwan's herbal medicines adverse reaction database and facilitate epidemiological analysis.Entities:
Mesh:
Year: 2021 PMID: 34728662 PMCID: PMC8564513 DOI: 10.1038/s41598-021-00704-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
ADR reports analyzed from the TADRRS-HM in Taiwan (1998–2016).
| 1998–2002 | 2003–2007 | 2008–2012 | 2013–2016 | Total | |
|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | n (%) | n (%) | |
| Herbal medicine* | 60 (32.4) | 339 (41.3) | 406 (52.4) | 136 (45.5) | 941 (45.3) |
| Folk herbals** | 9 ( 4.9) | 40 ( 4.9) | 22 ( 2.8) | 16 ( 5.3) | 87 ( 4.2) |
| RCT | 70 (37.8) | 337 (41.1) | 319 (41.2) | 116 (38.8) | 842 (40.5) |
| Other# | 46 (24.9) | 104 (12.7) | 28 (3.6) | 31 (10.4) | 209 (10.1) |
| Total | 185 (100) | 820 (100) | 775 (100) | 299 (100) | 2079 (100) |
TADRRS-HM Taiwan Adverse Drug Reaction Reporting System for Herbal Medicine.
*Herbal medicines included in the Taiwan Herbal Pharmacopeia or Chinese Pharmacopoeia Volume 1, as well as single herbs and herbal formulas registered as medicinal products, used in real-world conditions.
**Herbals not included in the Taiwan Herbal Pharmacopeia or Chinese Pharmacopoeia Volume 1.
#Involving herbals from clinical trials, foods, health foods, dietary supplement foods and Chinese herbal cuisine.
Figure 1Distributions of age and sex in the 1028 ADR reports involving single herbs, herbal formulae and folk herbals analyzed from the TADRRS-HM (1998–2016).
1028 ADR reports involving herbal medicines in the TADRRS-HM (1998–2016).
| Total numbers of ADR reports | |||||
|---|---|---|---|---|---|
| 1998–2002 | 2003–2007 | 2008–2012 | 2013–2016 | Total | |
| n (%) | n (%) | n (%) | n (%) | n (%) | |
| Medical personnel | 59 (85.5) | 360 (95) | 426 (99.5) | 145 (95.4) | 990 (96.3) |
| Doctors | 19 (27.5) | 121 (31.9) | 100 (23.4) | 27 (17.8) | 267 (26.0) |
| Pharmacists | 40 (58.0) | 212 (55.9) | 279 (65.2) | 90 (59.2) | 621 (60.4) |
| Nursing staff | 0 (0) | 2 (0.5) | 1 (0.2) | 0 (0) | 3 (0.3) |
| Others# | 0 (0) | 25 (6.6) | 46 (10.7) | 28 (19.3) | 99 (10.0) |
| Researchers | 5 (7.3) | 11 (2.9) | 0 (0) | 0 (0) | 16 (1.6) |
| Laypersons* | 0 (0) | 2 (0.5) | 2 (0.5) | 5 (3.3) | 9 (0.9) |
| Missing data** | 5 (7.3) | 6 (1.6) | 0 (0) | 2 (1.3) | 13 (1.3) |
| Total | 69 (100) | 379 (100) | 428 (100) | 152 (100) | 1028 (100) |
| North District | 36 (52.2) | 263 (69.4) | 145 (33.9) | 49 (32.2) | 493 (48.0) |
| Central District | 2 (2.9) | 9 (2.4) | 97 (22.7) | 68 (44.8) | 176 (17.1) |
| South District | 22 (31.9) | 54 (14.3) | 45 (10.5) | 15 (9.9) | 136 (13.2) |
| Eastern District | 9 (13.0) | 47 (12.4) | 117 (27.3) | 12 (7.9) | 185 (18.0) |
| Missing data | 0 (0) | 6 (1.6) | 24 (5.6) | 8 (5.3) | 38 (3.7) |
| Total | 69 (100) | 379 (100) | 428 (100) | 152 (100) | 1028 (100) |
TADRRS-HM Taiwan Adverse Drug Reaction Reporting System for Herbal Medicine.
*Patients and caregivers.
**Missing data refer to ADR records that were incompletely filled.
#ADR records were filled by medical personnel, without attribution of the person’s professional status.
Basic information from 1028 ADR reports in the TADRRS-HM (1998–2016).
| Basic information from 1028 ADR reports | Numbers of ADR reports |
|---|---|
| Yes | 136 (13.3) |
| No | 887 (86.7) |
| Missing data* | 5 (0.0) |
| Excessively enhanced drug effects** | 221 (21.5) |
| Unexpected side effects# | 733 (71.3) |
| Missing data | 74 (7.2) |
| Mild | 744 (72.4) |
| Moderate | 179 (17.4) |
| Severe | 67 (6.5) |
| Missing data | 38 (3.7) |
| Doubtful (≤ 0) | 135 (13.1) |
| Possible (1–4) | 608 (59.1) |
| Probable (5–8) | 267 (26.0) |
| Definite (≥ 9) | 18 (1.8) |
TADRRS-HM Taiwan Adverse Drug Reaction Reporting System for Herbal Medicine.
*Missing data refer to ADR records that were incompletely filled.
**Excessively enhanced drug effects refer to those that occur in patients prescribed a normal therapeutic dosage who experience amplified side effects from the medicine due to their individual characteristics. For example, during normal use/dosage, licorice can result in abdominal fullness, but some patients may experience excessive abdominal fullness.
#Unexpected side effects are those that are previously unknown in relation to a particular herb.
Numbers of adverse events in the TADRRS-HM (1998–2016), grouped by System Organ Class.
| System Organ Class | Numbers of ADR reports (n = 1028) |
|---|---|
| n (%) | |
| Gastrointestinal system disorders | 353 (33.4) |
| Skin and subcutaneous tissue disorders | 224 (21.2) |
| Immune system diseases | 158 (14.9) |
| Nervous system disorders | 123 (11.6) |
| General disorders | 78 (7.4) |
| Cardiac disorders | 75 (7.1) |
| Renal and urinary disorders | 63 (6.0) |
| Respiratory, thoracic and mediastinal disorders | 55 (5.2) |
| Psychiatric disorders | 50 (4.7) |
| Hepatobiliary diseases | 45 (4.3) |
| Investigations | 45 (4.3) |
TADRRS-HM Taiwan Adverse Drug Reaction Reporting System for Herbal Medicine.
The top 10 frequently reported herbals and formulas in TADRRS-HM, 1998–2016.
| Rank* | Single herbs (n = 2733) | Rank | Herbal formulas (n = 2909) | Rank | Folk herbals (n = 558) | |||
|---|---|---|---|---|---|---|---|---|
| 1 | Aconiti Radix | 22 | 1 | Xiao-Qing-Long-Tang | 21 | 1 | 11 | |
| 2 | Ephedrae Herba | 18 | 2 | Ma-Xing-Gan-Shi-Tang | 20 | 2 | 4 | |
| 3 | Glycyrrhizae Radix et Rhizoma | 17 | 2 | Jia-Wei-Xiao-Yao-San | 20 | 2 | 4 | |
| 3 | Salviae Miltiorrhizae Radix et Rhizoma | 17 | 4 | Xie-Fu-Zhu-Yu-Tang | 18 | 4 | 3 | |
| 3 | Angelicae Sinensis Radix | 17 | 5 | Zhi-Bo-Di-Huang-Wan | 17 | 4 | 3 | |
| 6 | Rhei Radix ET Rhizoma | 16 | 6 | Ban-Xia-Xie-Xin-Tang | 16 | |||
| 7 | Zingiberis Rhizoma | 13 | 7 | Liu-Wei-Di-Huang-Wan | 13 | |||
| 8 | Rehmanniae Radix | 11 | 7 | Xiang-Sha-Liu-Jun-Zi-Tang | 13 | |||
| 8 | Coptidis Rhizoma | 11 | 9 | Tian-Wang-Bu-Xin-Dan | 12 | |||
| 10 | Xanthii Fructus | 10 | 10 | Ge-Gen-Tang | 11 | |||
| 10 | Cicadae Periostracum | 10 | 10 | Long-Dan-Xie-Gan-Tang | 11 |
TADRRS-HM Taiwan Adverse Drug Reaction Reporting System for Herbal Medicine.
*Frequency of reports involving suspected herbal substances with a Naranjo scale score of ≥ 1 (a score of 1–4 is considered "possible", 5–8 "probable", and ≥ 9 "definite", as to the likelihood of the herb causing the ADR)[24].
The suspected AEs in ADRs relating to Aconiti Radix, the most frequently reported single herb (22 ADR reports).
| System organ class | Adverse event | n |
|---|---|---|
| Gastrointestinal system disorders | Nausea | 1 |
| Dry mouth | 4 | |
| Diarrhea | 2 | |
| Constipation | 1 | |
| Infections and infestations | Allergic reaction | 2 |
| Nervous system disorders | Paresthesia | 6 |
| Dizziness | 6 | |
| Syncope | 1 | |
| Psychiatric disorders | Delirium | 1 |
| Insomnia | 4 | |
| Respiratory, thoracic and mediastinal disorders | Dyspnea | 1 |
| Laryngeal inflammation | 1 | |
| Musculoskeletal and connective tissue disorders | Flank pain | 2 |
| Skin and subcutaneous tissue disorder | Pruritus | 1 |
| Rash acneiform | 2 | |
| General disorders and administration site conditions | Fever | 1 |
| Malaise | 2 | |
| Edema limbs | 2 | |
| Edema face | 1 | |
| Localized edema | 2 | |
| Cardiac disorders | Palpitations | 3 |
| Sinus bradycardia | 4 | |
| Ventricular arrhythmia | 1 | |
| Chest pain—cardiac | 2 | |
| Kidney and urinary system diseases | Acute kidney injury | 1 |
| Dysuria | 3 | |
| Vascular disorders | Hypotension | 4 |